The Coca-Cola Company (NYSE:KO) is giving SodaStream International Ltd. (SODA) a hand in scaring away short sellers. Since Coca-Cola agreed Feb. 5 to buy a 10 percent stake in Green Mountain Coffee Roasters Inc. (GMCR), a company developing a make-your-own, single-serve product similar to SodaStream’s, short interest on the stock has fallen. It dropped to 22 percent of the Israeli beverage maker’s outstanding shares on Feb. 14 from an 18-month high of 30 percent at the start of the year, according to data compiled by Bloomberg and Markit, a London-based research firm The Coca-Cola Company (NYSE:KO) stock decreased -3.75% and finished the last session at $37.47. The EPS of the stock remained 1.93. Company’s market capitalization is $165.46 billion.
AstraZeneca plc (ADR) (NYSE:AZN) will begin trading ex-dividend on February 19, 2014. A cash dividend payment of $1.9 per share is scheduled to be paid on March 24, 2014. Shareholders who purchased AZN stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 111.11% increase over the prior quarter. AstraZeneca plc (ADR) (NYSE:AZN) stock opened at $68.01 in last trading session, and closed at $68.15, trading in the range of $67.88 – $68.35. The stock showed a positive weekly performance of 5.81%.
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) said its experimental treatment for Huntington disease met its primary goals of safety as well as showing significant improvement in cognitive function in a Phase II study. Shares rose 13% to $8.21 in recent premarket trading. Through Friday’s close, the stock has more than tripled in the past 12 months. “The observation of significant improvement in executive function [cognitition] with PBT2 in this clinical trial for Huntington disease and the previously reported Alzheimer’s trial, suggests a common mechanism for neurodegeneration in these diseases based on metal interactions,” said Dr. Rudy Tanzi, professor of neurology at Harvard Medical School and Prana’s chief scientific adviser. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) shares closed at $10.10 on last trade day, by gaining 39.31%. Stock 52 week range is $2.09 – $13.29. Company’s market capitalization is $411.48 million.
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Blucora Inc (NASDAQ:BCOR) concerning possible violations of federal securities laws. The investigation is focused on the Company’s business and operations. Blucora Inc (NASDAQ:BCOR) stock opened at $19.95 in last trading session and closed at $21.70. The 52 week range of the stock is $14.25 – $30.12 and the day range was $19.43 – $21.90.